نوع مقاله : Original Article(s)
نویسندگان
1 استادیار، گروه پریودنتیکس، دانشکدهی دندانپزشکی، دانشگاه علوم پزشکی قزوین، قزوین، ایران
2 دانشیار، گروه داخلی، دانشکدهی پزشکی، دانشگاه علوم پزشکی قزوین، قزوین، ایران
3 دستیار تخصصی، گروه کودکان، دانشکدهی دندانپزشکی، دانشگاه آزاد اسلامی، واحد تهران، تهران، ایران
چکیده
کلیدواژهها
عنوان مقاله [English]
نویسندگان [English]
Background: There are contradictory results of different studies about the effect of periodontal treatment on metabolic control of diabetes. Due to the importance of management of the patients, the purpose of this study was to examine the effect of periodontal therapy [scaling and root planning (SRP)] with doxycycline on glycemic control in patients with type 2 diabetes mellitus.Methods: In this double-blind randomized controlled clinical trial, 40 patients with type 2 diabetes mellitus who had moderate periodontitis were treated with scaling and root planning + placebo (SRP; n = 20) or with scaling and root planning + doxycycline 100 mg/day, for 21 days (SRP + Doxy; n=20). Periodontal parameters including bleeding on probing (BOP), clinical attachment loss (CAL), plaque index (PI), and probing depth (PD), also metabolic parameter (HbA1c) were recorded at baseline and 3 months after the treatment.Findings: After 3 month, all periodontal parameters and HbA1c showed significant improvement in both groups (P < 0.001). The reduction of all periodontal parameters and HbA1c was not significantly different between the groups in this study (P for BOP = 0.799; P for CAL = 0.667; P for PI = 0.253; P for PD = 0.989; and P for HbA1c = 0.301).Conclusion: Periodontal treatment with the adjunctive systemic doxycycline may influence the systemic conditions of patients with type 2 diabetes mellitus, but no statistical differences was observed between the control and treatment groups. Therefore, confirmatory studies with controlled diabetes are necessary.
کلیدواژهها [English]